AVISTONE PHARMACEUTICALS
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
AVISTONE PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Oncology
Founded:
2011-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.en.avistonebio.com
Total Employee:
251+
Status:
Active
Contact:
010- 84148921
Email Addresses:
[email protected]
Total Funding:
340.69 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Mobile Non Scaleable Content Pound Sterling Japanese Yen
Similar Organizations
Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
ArcherDX
ArcherDX is a biotechnology firm specializing in cancer research.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-10 | Pearl Biotech | Pearl Biotech acquired by Avistone Pharmaceuticals | N/A |
Investors List
Bain Capital
Bain Capital investment in Series B - Avistone Pharmaceuticals
SDIC Fund Management
SDIC Fund Management investment in Series B - Avistone Pharmaceuticals
IDG Capital
IDG Capital investment in Series B - Avistone Pharmaceuticals
Yanchuang Capital
Yanchuang Capital investment in Series B - Avistone Pharmaceuticals
Cathay Capital
Cathay Capital investment in Series B - Avistone Pharmaceuticals
Bain Capital
Bain Capital investment in Series A - Avistone Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series A - Avistone Pharmaceuticals
Primavera Capital Group
Primavera Capital Group investment in Series A - Avistone Pharmaceuticals
Official Site Inspections
http://www.en.avistonebio.com
- Host name: hn.kd.ny.adsl
- IP address: 123.6.40.242
- Location: China
- Latitude: 34.6836
- Longitude: 113.5325
- Timezone: Asia/Shanghai
More informations about "Avistone Pharmaceuticals"
Beijing Avistone Pharmaceuticals Biotechnology Co., …
Inception of Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd.; launch of Vebreltinib GBM Phases II/III critical registration for clinical trials; patent approved for Vebreltinib precision treatment for glioma; operating mechanism and …See details»
Avistone Pharmaceuticals - Crunchbase Company …
En.avistonebio.com ; 30,874; Highlights. Acquisitions 1. obfuscated. Total Funding Amount . Unlock for free . Employee Profiles 1. ... Contact Email [email protected]; Phone Number 010- 84148921; Avistone …See details»
Core Team-Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd.
Email: [email protected]. Company Profile. Social Responsibility Patient Care Accolades. Service Scope. Clinical Study Scientific Research & Innovation Business Development ©2022 …See details»
Avistone Biotechnology Co., Inc | LinkedIn
Avistone Biotechnology Co., Inc | 246 followers on LinkedIn. Avistone is an Innovative Global Oncology Company Focused on Targeted Therapeutics for Lung Cancer | Avistone is an oncology company ...See details»
Avistone Biotechnology - BIO International Convention 2024
Jun 3, 2024 Founded in 2010, Avistone Biotechnology is a private, global Oncology company, focused on targeted therapeutics. The company’s pipeline comprises of six assets, including: …See details»
Overview, News & Similar companies - ZoomInfo.com
Apr 24, 2024 Avistone Biotechnology contact info: Phone number: +86 1084148921 Website: www.avistonebio.com What does Avistone Biotechnology do? Based in Beijing, China, …See details»
Biotech co Avistone Pharma raises $200 mln in fresh funding
Dec 8, 2021 Biotechnology company Avistone Pharmaceuticals said on Wednesday it has raised $200 million in fresh funding led by healthcare investment firm Vivo Capital.See details»
Avistone Pharmaceuticals Secures $200 Million Strategic …
Beijing, San Francisco and Boston, December 8, 2021 – Avistone Pharmaceuticals (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology …See details»
Avistone Scores $200 Million to Target Molecular Drivers of Cancer
Avistone Scores $200 Million to Target Molecular Drivers of CancerSee details»
Avistone Announces Results from Two Sponsored Clinical …
BEIJING, June 04, 2024--Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision …See details»
Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd.
Email: [email protected]. Company Profile. Social Responsibility Patient Care Accolades. Service Scope. Clinical Study Scientific Research & Innovation Business Development ©2022 …See details»
Avistone Announces Updates on ANS014004 - Morningstar
Oct 4, 2024 Avistone Announces Updates on ANS014004. Beijing Avistone Biotechnology Co., Ltd (also referred to as “Avistone Biotechnology” or “Avistone”), an innovative biotechnology …See details»
Avistone Announces the Approval of Vebreltinib as the First MET …
BEIJING, April 25, 2024--Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision …See details»
Avistone Pharmaceuticals Secures $200 Million Strategic …
Dec 8, 2021 Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital and Primavera CapitalSee details»
Chinese Cancer Biotech Avistone Raises $200 Million in Funding …
Dec 9, 2021 (Bloomberg) — Chinese biotechnology company Avistone Pharmaceuticals raised more than $200 million in a series A funding round led by Vivo Capital in one of the largest …See details»
Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd.-Science …
Email: [email protected]. Company Profile. Social Responsibility Patient Care Accolades. Service Scope. Clinical Study Scientific Research & Innovation Business Development ©2022 …See details»
Avistone Announces Updates on ANS014004 - Business Wire
Oct 4, 2024 Beijing Avistone Biotechnology Co., Ltd (also referred to as “Avistone Biotechnology” or “Avistone”), an innovative biotechnology company focused on pSee details»
Avistone Completes $200 Million-plus Fundraising, with Vivo …
On December 9, 2021, Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd ("Avistone ") announced the closure of Series A funding, raising over $200 million.Vivo Capital was the lead …See details»
News and Announcements-Beijing Avistone Pharmaceuticals …
Mar 15, 2022 On December 9, 2021, Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd ("Avistone"), a company focusing on the research of targeted drug for precision treatment …See details»